Details for New Drug Application (NDA): 091039
✉ Email this page to a colleague
The generic ingredient in DAPTOMYCIN is daptomycin. There are ten drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the daptomycin profile page.
Summary for 091039
Tradename: | DAPTOMYCIN |
Applicant: | Teva Pharms Usa |
Ingredient: | daptomycin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 091039
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 500MG/VIAL | ||||
Approval Date: | Mar 25, 2016 | TE: | AP | RLD: | No |
Complete Access Available with Subscription